R-CHOP 14 - Rituximab 375 / Cyclophosphamid 750 / Doxorubicin 50 / Vincristin 2 / Prednisolon 100, diffus großzelliges B-Non-Hodgkin-Lymphom, Zyklus 1-6 (PID112 V1.1)
Amphotericin B (ATC A07AA07)
- EMA EPAR: Amphotericin B (cresemba)
- FachInfo: Amphotericin B (Ampho-Moronal®, Dermapharm, Lutschtabletten, 10 mg, Ampho-Moronal® Suspension, 100 mg/ml, Ampho-Moronal® Tabletten, 100 mg, p.o.)
- PC Compound: Amphotericin B
- PM Term Suche: Amphotericin
Cotrimoxazol (ATC J01EE01)
- PC Compound: Cotrimoxazole
Cyclophosphamid (ATC L01AA01)
- PC Compound: Cyclophosphamide
- PC Substance: Cyclophospamid
Dimetinden (ATC R06AB03)
- FachInfo: Dimentinden (Fenistil®, NOVARTIS, Dimetindenmaleat 1mg/ml, i.v.)
- PC Compound: Dimetinden
- PC Substance: Dimetinden
- PC Substance: Dimetindenmaleat
Doxorubicin (ATC L01DB01)
- FachInfo: Doxorubicin (Doxorubicinhydrochlorid Teva® 2 mg/ml, i.v.)
- PC Compound: Doxorubicin
- PC Substance: DoxorubicinHCl
- Rote Liste: Doxorubicin
Granisetron (ATC A04AA02)
- EMA EPAR: Granisetron (Sancuso, 3.1 mg/24 hours transdermal
- EMA URL: Kytril, granisetron
- FachInfo: Granisetron (Granisetron Kabi, 1 mg/ml, i.v.)
- PC Compound: Granisetron
- PC Substance: Granisetron
Mesna (ATC V03AF01)
- FachInfo: Mesna (Uromitexan®, Baxter Oncology, 400 mg, i.v.)
- FachInfo: Mesna (Uromitexan, Baxter Oncology, Tbl. 400mg, 600mg, p.o.)
- PC Compound: Mesna
- PC Substance: Mesna
- Rote Liste: Mesna
- URL: Mesna WHO 2009
Paracetamol (ATC N02BE01)
- PC Compound: Paracetamol
Pegfilgrastim (ATC L03AA13)
- EMA EPAR: Pegfilgrastim (neulasta)
- FachInfo: Pegfilgrastim (Neulasta®, AMGEN, 6 mg, s.c.)
- PC Substance: Pegfilgrastim
- PC Substance: Pegfilgrastim
- Rote Liste: Pegfilgrastim
Prednisolon (ATC H02AB06)
- PC Compound: Prednisolone
Rituximab (ATC L01FA01)
- EMA EPAR: Rituximab (mabthera)
- FachInfo: Rituximab (MabThera® 100 mg, Roche, MabThera® 500 mg, i.v.)
- FachInfo: Rituximab (MabThera®, Roche, 1.400 mg, s.c.)
- PC Substance: Rituximab
- PC Substance: Rituximab
- PEI : Rote Hand Brief - Rituximab (MabThera®): HBV Screening vor Behandlung (11/2013), Informationen zu Stevens-Johnson-Syndrom (04/2013), Tödliche infusionsbedingte Reaktionen bei Patienten mit RA (08/2011)
- Rote Liste: Rituximab
Vincristin (ATC L01CA02)
- FachInfo: Vincristin (Vincristinsulfat-Teva ®1 mg/ml, i.v.)
- PC Compound: Vincristine
- PC Substance: Vincristin
- Rote Liste: Vincristin
- URL: Vincristin Daten Schweiz
- URL: Aktionsbündnis Patientensicherheit - Eine Handlungsempfehlung der AG Arzneimitteltherapiesicherheit